REFRACTORY GRADE 3A FOLLICULAR LYMPHOMA
Clinical trials for REFRACTORY GRADE 3A FOLLICULAR LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY GRADE 3A FOLLICULAR LYMPHOMA trials appear
Sign up with your email to follow new studies for REFRACTORY GRADE 3A FOLLICULAR LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo aims to tackle lymphoma in communities often left behind
Disease control Recruiting nowThis early-stage trial tests two oral drugs, zanubrutinib and sonrotoclax, for people with B-cell non-Hodgkin lymphoma that has returned or not responded to prior treatment. The study focuses on Black, Hispanic, and other underrepresented groups to improve access and outcomes. Ab…
Matched conditions: REFRACTORY GRADE 3A FOLLICULAR LYMPHOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 26, 2026 05:43 UTC
-
New drug duo shows promise for Tough-to-Treat lymphoma
Disease control Recruiting nowThis phase 2 trial tests a combination of two targeted drugs, mosunetuzumab and polatuzumab vedotin, in 41 adults with follicular lymphoma that has come back or not responded to prior therapy. The goal is to see if the combo can shrink or eliminate cancer cells while monitoring s…
Matched conditions: REFRACTORY GRADE 3A FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 18, 2026 12:11 UTC